Cargando…
Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention
BACKGROUND: The relation between monocyte to high-density lipoprotein cholesterol ratio (MHR) and coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains controversial. The present study aims to assess the prognostic value of MHR in patients with CAD who underwent P...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805452/ https://www.ncbi.nlm.nih.gov/pubmed/31640740 http://dx.doi.org/10.1186/s12944-019-1116-2 |
_version_ | 1783461387873288192 |
---|---|
author | Wu, Ting-Ting Zheng, Ying-Ying Chen, You Yu, Zi-Xiang Ma, Yi-Tong Xie, Xiang |
author_facet | Wu, Ting-Ting Zheng, Ying-Ying Chen, You Yu, Zi-Xiang Ma, Yi-Tong Xie, Xiang |
author_sort | Wu, Ting-Ting |
collection | PubMed |
description | BACKGROUND: The relation between monocyte to high-density lipoprotein cholesterol ratio (MHR) and coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains controversial. The present study aims to assess the prognostic value of MHR in patients with CAD who underwent PCI. METHODS: A total of 673 CAD patients were retrospectively enrolled and divided into four groups according to MHR values. Multivariate Cox regression analysis was performed to study the effects of different variables to clinical outcomes reported as major adverse cardiac events (MACE) and all-cause mortality (ACM). RESULTS: In a multivariate Cox analysis, after adjustment of other confounders, MHR was found to be an independent predictor of ACM (HR: 3.655; 95% CI: 1.170–11.419, P = 0.026) and MACE (HR =2.390, 95% CI 1.379–4.143, p < 0.002). Having a MHR in the third and fourth quartile were associated with a 2.83-fold and 3.26 -flod increased risk of MACE. CONCLUSIONS: MHR is an independent predictor of ACM and MACE in CAD patients undergoing PCI. |
format | Online Article Text |
id | pubmed-6805452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68054522019-10-24 Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention Wu, Ting-Ting Zheng, Ying-Ying Chen, You Yu, Zi-Xiang Ma, Yi-Tong Xie, Xiang Lipids Health Dis Research BACKGROUND: The relation between monocyte to high-density lipoprotein cholesterol ratio (MHR) and coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains controversial. The present study aims to assess the prognostic value of MHR in patients with CAD who underwent PCI. METHODS: A total of 673 CAD patients were retrospectively enrolled and divided into four groups according to MHR values. Multivariate Cox regression analysis was performed to study the effects of different variables to clinical outcomes reported as major adverse cardiac events (MACE) and all-cause mortality (ACM). RESULTS: In a multivariate Cox analysis, after adjustment of other confounders, MHR was found to be an independent predictor of ACM (HR: 3.655; 95% CI: 1.170–11.419, P = 0.026) and MACE (HR =2.390, 95% CI 1.379–4.143, p < 0.002). Having a MHR in the third and fourth quartile were associated with a 2.83-fold and 3.26 -flod increased risk of MACE. CONCLUSIONS: MHR is an independent predictor of ACM and MACE in CAD patients undergoing PCI. BioMed Central 2019-10-22 /pmc/articles/PMC6805452/ /pubmed/31640740 http://dx.doi.org/10.1186/s12944-019-1116-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Wu, Ting-Ting Zheng, Ying-Ying Chen, You Yu, Zi-Xiang Ma, Yi-Tong Xie, Xiang Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention |
title | Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention |
title_full | Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention |
title_fullStr | Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention |
title_full_unstemmed | Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention |
title_short | Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention |
title_sort | monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805452/ https://www.ncbi.nlm.nih.gov/pubmed/31640740 http://dx.doi.org/10.1186/s12944-019-1116-2 |
work_keys_str_mv | AT wutingting monocytetohighdensitylipoproteincholesterolratioaslongtermprognosticmarkerinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryintervention AT zhengyingying monocytetohighdensitylipoproteincholesterolratioaslongtermprognosticmarkerinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryintervention AT chenyou monocytetohighdensitylipoproteincholesterolratioaslongtermprognosticmarkerinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryintervention AT yuzixiang monocytetohighdensitylipoproteincholesterolratioaslongtermprognosticmarkerinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryintervention AT mayitong monocytetohighdensitylipoproteincholesterolratioaslongtermprognosticmarkerinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryintervention AT xiexiang monocytetohighdensitylipoproteincholesterolratioaslongtermprognosticmarkerinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryintervention |